|
|
|
ICR
Steering Committee Through July 31, 2009 |
|
|
|
|
The ICR was an interactive group of laboratories
whose primary purpose was to supply investigators
with clinical grade islets for ICR-approved studies.
The Steering Committee (SC) oversaw the general
functions of the ICR, based on the Policy
and Procedures document, and evaluated the clinical
and scientific merit of submitted applications.
The SC determined through the adoption of the Matching Algorithm
for Islet Distribution (MAID) which ICR facility would
produce the islets for each ICR-approved request.
The ICR SC was informed of, and monitored serious adverse
events involving ICR-supported protocols when the
clinical investigator reported them to local and
Federal oversight groups in accordance with institutional,
state, and Federal guidelines. The SC did not serve
as a Data and Safety Monitoring Board for individual
transplantation protocols.
The ICR Steering Committee
was comprised of the chairman, the Administrative
and Bioinformatics Coordinating Center (ABCC) Director,
10 ICR directors, 2 outside experts, a Food and
Drug Administration (FDA) representative, a National Institutes
of Diabetes and Digestive Kidney Diseases (NIDDK)
representative, a Juvenile Diabetes Research Foundation
International (JDRFI) representative, and a National
Center for Research Resources (NCRR) representative.
|
|
|
|
|
|